Leukocyte count and fibrinogen are associated with carotid and femoral intima-media thickness in a risk population for diabetes.

[1]  Werner Poewe,et al.  Chronic Infections and the Risk of Carotid Atherosclerosis: Prospective Results From a Large Population Study , 2001, Circulation.

[2]  H. Brenner,et al.  Association between C-reactive protein and features of the metabolic syndrome: a population-based study. , 2000, Diabetes care.

[3]  G. Lowe,et al.  Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. , 2000, The New England journal of medicine.

[4]  C. Zoccali,et al.  Inflammation is associated with carotid atherosclerosis in dialysis patients , 2000, Journal of hypertension.

[5]  S. Haffner,et al.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). , 2000, Circulation.

[6]  G. Lowe,et al.  Lipoprotein-associated Phospholipase A2 (Lp PLA2), an inflammatory marker and novel independent risk factor in the West of Scotland Coronary Prevention Study (WOSCOPS) , 2000 .

[7]  R. Ross.  Atherosclerosis is an inflammatory disease , 1999 .

[8]  S. Coppack,et al.  C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[9]  M. Hanefeld,et al.  Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors. , 1999, Diabetes care.

[10]  R. Kronmal,et al.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.

[11]  G. Noll,et al.  Pathogenesis of atherosclerosis: a possible relation to infection. , 1998, Atherosclerosis.

[12]  M. Laakso,et al.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. , 1998, The New England journal of medicine.

[13]  R. Tracy.  Inflammation in cardiovascular disease: cart, horse, or both? , 1998, Circulation.

[14]  T. Temelkova-Kurktschiev,et al.  Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individuals , 1998, Diabetologia.

[15]  L H Kuller,et al.  Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[16]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[17]  S. Thompson,et al.  Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.

[18]  J. Boyle,et al.  ASSOCIATION OF CORONARY PLAQUE RUPTURE AND ATHEROSCLEROTIC INFLAMMATION , 1997, The Journal of pathology.

[19]  J. Seidell,et al.  The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals , 1996, Journal of internal medicine.

[20]  B. Spiegelman,et al.  Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link , 1994, Diabetes.

[21]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[22]  M. Nieminen,et al.  Chlamydia Pneumoniae‐Specific Circulating Immune Complexes in Patients With Chronic Coronary Heart Disease , 1993, Circulation.

[23]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[24]  D. Siscovick,et al.  Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. , 1992, JAMA.

[25]  K. Anderson,et al.  White blood cell count and cardiovascular disease. Insights from the Framingham Study. , 1992, JAMA.

[26]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[27]  T Gustavsson,et al.  Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. , 1991, Clinical physiology.

[28]  P C Elwood,et al.  Fibrinogen, Viscosity, and White Blood Cell Count Are Major Risk Factors for Ischemic Heart Disease: The Caerphilly and Speedwell Collaborative Heart Disease Studies , 1991, Circulation.

[29]  P Pignoli,et al.  Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. , 1986, Circulation.

[30]  J. S. Stevenson.  In older adults , 1980 .

[31]  B. Gandevia,et al.  DECLARATION OF HELSINKI , 1964, Definitions.

[32]  J. W. Sever.  THE WHITE BLOOD CELL COUNT , 1933 .

[33]  Z. Kis,et al.  Chronic infections and atherosclerosis. , 2001, Acta microbiologica et immunologica Hungarica.

[34]  M. Hanefeld,et al.  Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia an underestimated evil? , 2000, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[35]  Eary,et al.  CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS , 2000 .

[36]  I. Sartori.  Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris , 1996 .

[37]  R. Cotran,et al.  The pathogenesis of atherosclerosis: atherogenesis and inflammation. , 1988, Laboratory investigation; a journal of technical methods and pathology.